Birdwatch Archive

Birdwatch Note Rating

2023-04-21 19:21:06 UTC - SOMEWHAT_HELPFUL

Rated by Participant: 861AC5329C7550A5F5EAD859F3BD890F51C233A4DFEA0F2BF530F89F15902B21
Participant Details

Original Note:

Ivermectin tablets are approved by the FDA to treat people with intestinal strongyloidiasis and onchocerciasis, two conditions caused by parasitic worms. Randomized controlled trials show Ivermectin does not have efficacy in COVID-19, cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub3/full https://www.reuters.com/article/factcheck-nobel-ivermectin/fact-check-2015-nobel-prize-for-ivermectin-intended-for-treatment-of-parasitic-infections-doesnt-prove-its-efficacy-on-covid-19-idUSL1N2QB2XA https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2789362 https://jamanetwork.com/journals/jama/fullarticle/2777389 https://www.nejm.org/doi/full/10.1056/NEJMoa2115869 https://www.nejm.org/doi/full/10.1056/NEJMoa2201662

All Note Details

Original Tweet

All Information

  • noteId - 1649444853502164997
  • participantId -
  • raterParticipantId - 861AC5329C7550A5F5EAD859F3BD890F51C233A4DFEA0F2BF530F89F15902B21
  • createdAtMillis - 1682104866978
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - SOMEWHAT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1649444853502164997861AC5329C7550A5F5EAD859F3BD890F51C233A4DFEA0F2BF530F89F15902B21